@Anjo-Roch
Re
"Mesoblast has impressed investors with news that almost half of the heart failure patients involved in a late stage clinical trial have been successfully protected for a whole year from a sudden or significant worsening of their condition"
How could Mesoblast know this and yet be blinded from interim results as previously announced?
I know you are just quoting the online article, but all the official ASX announcement said was that they have passed the futility test - anything beyond that is a guess isn't it?
AFR - 10 Aril 2017, page-5
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |